Leave Your Message
Clinically validated antibacterial pads designed for bacterial vaginosis treatment and everyday gynecological protection — trusted by over 6 million women.
The global women's intimate health market is undergoing rapid transformation, driven by rising health awareness and biotech innovation.
The global market for adult pads designed for gynecological health has emerged as one of the fastest-growing segments within the broader feminine hygiene industry. Valued at over USD 28 billion in 2024, the sector is projected to maintain a compound annual growth rate (CAGR) of approximately 7.4% through 2030. This momentum is fueled by increasing awareness of women's intimate health, rising disposable incomes in emerging economies, and a generational shift toward proactive healthcare rather than reactive treatment.
In China alone, the gynecological health product market has expanded dramatically over the past decade. Domestic manufacturers — led by pioneering enterprises such as Shaanxi Wanan Pharmaceutical Co., Ltd. — have invested heavily in R&D, clinical validation, and quality certification to meet both domestic demand and international export standards. The integration of pharmaceutical-grade ingredients, such as silver ions and natural botanical extracts, into daily-use pads has redefined consumer expectations and opened entirely new commercial channels.
Modern production of adult pads for gynecological health demands a level of precision and quality control that far exceeds conventional sanitary pad manufacturing. Leading factories now operate under dual certification frameworks — ISO 9001 for quality management and ISO 13485 for medical device standards — ensuring that every product batch meets rigorous safety and efficacy benchmarks before reaching consumers.
Advanced manufacturing lines incorporate cleanroom environments, automated antimicrobial coating processes, and real-time quality sensors to guarantee consistent silver-ion distribution across pad surfaces. The use of medical-grade non-woven fabrics, breathable backsheets, and hypoallergenic adhesives reflects a deep commitment to skin compatibility — a critical requirement for products used in intimate areas over extended periods.
China has positioned itself as the world's leading supplier of OEM and ODM gynecological health pads, with factory-direct pricing models enabling global brands, healthcare distributors, and pharmacy chains to access high-quality products at competitive price points. Wanan Pharmaceutical's manufacturing facility in Shaanxi Province exemplifies this model — combining a USD 8 million fixed-asset base with a dedicated scientific research team to drive continuous product innovation.
Several macro-trends are converging to reshape the adult pads for gynecological health sector over the coming years. Personalization and data-driven product development are gaining traction, with companies exploring smart pad technologies that can detect pH changes or moisture levels to alert users to potential infections. While still in early commercialization stages, these innovations signal a future where intimate hygiene products actively participate in women's health monitoring ecosystems.
Sustainability is another powerful force. Consumers and regulators alike are demanding biodegradable materials, plastic-free packaging, and transparent supply chains. Forward-looking manufacturers are investing in plant-based absorbent cores and compostable outer layers without compromising antibacterial performance — a technically challenging but commercially rewarding frontier.
The e-commerce revolution has also democratized access to specialized gynecological health pads. Online health platforms, subscription box services, and direct-to-consumer brands have made it possible for women in rural or underserved regions to access medical-grade intimate care products previously available only through hospital pharmacies or specialty clinics.
From biotech materials to digital health integration, the future of adult pads is being written today.
Silver ions disrupt bacterial cell membranes at a molecular level, providing broad-spectrum antimicrobial protection against common pathogens responsible for bacterial vaginosis, candidiasis, and trichomoniasis — without disturbing healthy vaginal flora.
Traditional Chinese medicine ingredients — including Sophora flavescens, Cnidium monnieri, and Phellodendron bark — are being scientifically validated and incorporated into pad formulations, merging ancient healing wisdom with modern biomedical engineering.
Next-generation pads embedded with biosensors capable of detecting vaginal pH, moisture anomalies, and early infection markers represent the frontier of connected women's health — integrating seamlessly with mobile health applications and telemedicine platforms.
Organic cotton cores, bamboo-fiber topsheets, and fully compostable packaging are replacing petroleum-based materials — addressing both environmental concerns and the growing consumer preference for clean, toxin-free intimate care products.
The boundary between pharmaceutical products and consumer hygiene goods is dissolving. ISO 13485-certified manufacturing processes are enabling brands to position adult gynecological pads as evidence-based therapeutic devices recommended by healthcare professionals.
Chinese manufacturers are leveraging cross-border e-commerce, B2B health platforms, and international trade partnerships to bring premium gynecological health pads to women across Southeast Asia, the Middle East, Africa, and Latin America.
One of the most impactful applications of adult pads for gynecological health is in post-clinical recovery settings. Following gynecological procedures such as colposcopy, cervical biopsy, IUD insertion, or treatment for cervical erosion, women require gentle yet highly effective antimicrobial protection to prevent secondary infections during the healing process. Silver-ion pads offer a non-invasive, topical antimicrobial layer that supports recovery without the systemic side effects associated with oral antibiotics.
Hospitals and outpatient gynecological clinics in China increasingly recommend Zimeishu-type antibacterial pads as part of post-procedure care protocols — a trend that is beginning to gain traction in international healthcare markets as clinical evidence accumulates.
For the majority of users, adult gynecological pads serve as a daily preventive healthcare tool. Women with a history of recurrent bacterial vaginosis, yeast infections, or vulvovaginal irritation benefit significantly from the continuous low-level antimicrobial environment created by silver-ion pads. Unlike medicated creams or suppositories that require active application, therapeutic pads integrate seamlessly into existing hygiene routines — dramatically improving treatment adherence and long-term outcomes.
The convenience factor is particularly significant for working women, frequent travelers, and those in regions with limited access to gynecological healthcare facilities. A high-quality antibacterial pad effectively extends the reach of preventive gynecological care beyond the clinic and into everyday life.
The postpartum period represents one of the highest-risk windows for gynecological infections. Vaginal delivery, episiotomy wounds, and hormonal changes create conditions highly susceptible to bacterial and fungal overgrowth. Postpartum-specific adult pads incorporating silver-ion technology and soothing botanical extracts address this critical need — providing antimicrobial protection, moisture management, and gentle skin care simultaneously.
Maternity hospitals and postnatal care centers represent a significant institutional market for premium gynecological health pads, with procurement decisions increasingly influenced by clinical evidence and ISO certification status.
Declining estrogen levels during perimenopause and menopause lead to vaginal atrophy, reduced natural lubrication, and increased susceptibility to urinary tract infections and vaginal infections. Adult pads formulated with pH-balancing agents and antimicrobial compounds offer menopausal women a non-hormonal supportive option for maintaining intimate health and comfort — a demographic that is both large and significantly underserved by current product offerings.
Physically active women — athletes, fitness enthusiasts, and outdoor workers — face elevated risks of intimate irritation and infection due to prolonged moisture exposure, friction, and sweat accumulation. Ultra-thin, high-absorbency antibacterial pads designed for active use combine moisture-wicking technology with antimicrobial protection, enabling women to maintain gynecological health without compromising performance or comfort during physical activity.
A trusted pioneer in women's pharmaceutical health since 1995 — combining scientific rigor, clinical expertise, and manufacturing excellence.
Founded in 1995, Shaanxi Wanan Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise integrating scientific research, production, and sales. With fixed assets of approximately RMB 65 million Yuan (USD 8 million) and annual sales exceeding RMB 50 million Yuan (USD 6 million), Wanan Pharmaceutical employs over 300 professionals, 50% of whom are medical specialists.
The company's scientific infrastructure includes a dedicated research group of 5 medical doctors and 11 masters, supported by an expert advisory panel of over 70 gynecological physicians. This deep clinical foundation ensures that every product is developed with rigorous scientific backing and real-world therapeutic relevance.
The flagship Zimeishu silver-ion gynecological pad has demonstrated prominent clinical efficacy in preventing and treating gynecological inflammations, earning the trust of over 6 million women across China. The product's sales network now spans most major cities nationwide, with growing international distribution channels serving markets across Asia, the Middle East, and beyond.
Wanan's products have achieved ISO 9001:2000 international quality management certification and ISO 13485:2003 international medical equipment standard certification — dual endorsements that validate the company's commitment to manufacturing excellence and patient safety at the highest global standards.
In order to improve the life quality of women worldwide, the staff of Wanan — adhering to the conception of "Working with credibility and seeking for perfection" — take Zimeishu as the carrier of their deep passion, and will surely make a meaningful contribution to the health and wellbeing of women everywhere. We welcome partnerships with distributors, healthcare institutions, and OEM clients globally.
Inquire Now →Explore our full range of adult pads engineered for diverse gynecological health needs — from daily care to targeted therapeutic applications.